Baylor College of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Baylor College of Medicine sits in the top decile of US sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count).

616 total trials 93 currently recruiting 376 completed early-phase tilt top decile by trial count

Baylor College of Medicine: 616 sponsored US clinical trials, 93 recruiting.

Baylor College of Medicine sponsors 616 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 376 completed. 59 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Non-Hodgkin Lymphoma, with 7 trials.

Top-decile sponsor footprint

Baylor College of Medicine ranks in the top decile of sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 47/100

376 of 452 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

616 total, page 7 of 13

COMPLETED Phase 1

Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)

NCT02973113

COMPLETED Phase 1

Administration of Donor MultiTAA-Specific T Cells for ALL

NCT02475707

TERMINATED

Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients

NCT02697123

COMPLETED Phase 2

Novel Offloading for Diabetic Foot Ulcers With PulseFlow: A Prospective Study

NCT02783066

TERMINATED NA

Adjunctive Transcranial Direct Current Stimulation

NCT02665988

COMPLETED NA

Smart and Secure Children Program for Preschool Obesity

NCT02681874

COMPLETED

Detection of Exocrine Pancreatic Insufficiency in Patients With Diarrhea and Bloating

NCT03407534

TERMINATED Phase 4

Effect of Dapagliflozin on Inflammation and Endothelial Function

NCT02608905

TERMINATED Phase 2

Treatment of Adult Patients With Hemoglobin SC Disease (SCYTHE)

NCT02640573

COMPLETED

Early Genetic and Environmental Influences on Eating - The Baylor Infant Twins Study

NCT04306523

COMPLETED NA

Proposed Meal Changes for CACFP: Impact on Child Food Intake and Costs

NCT02789215

COMPLETED Phase 1

Complementary Combination Therapy for Cocaine Dependence

NCT02538744

COMPLETED

Individual Blood Pressure Optimization Based on Cerebral Autoregulation After Implantation of Continuous-flow LVAD

NCT03093012

TERMINATED

The Utility of Time Segmental Withdrawal During Screening Colonoscopy for Increasing Adenoma Detection Rate.

NCT02538406

COMPLETED

Growth and Microbiome Development in Very Low Birth Weight Infants Fed Primarily Mother's Own Milk vs. Donor Human Milk

NCT02573779

COMPLETED NA

NextSteps Intervention for Advanced Cancer Patients and Caregivers

NCT04885439

COMPLETED NA

Cap Assisted Colonoscopy Enhances Quality Based Competency in Colonoscopy Among Trainees

NCT02472730

COMPLETED NA

Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants

NCT02475434

COMPLETED Phase 1

Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children

NCT02335905

COMPLETED Early Phase 1

Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders

NCT02484053

COMPLETED NA

Saving Lives at Birth: Primary Prevention of Periodontal Disease in Relation to Preterm Birth in Malawi

NCT02333227

COMPLETED Phase 2

Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors

NCT02197897

COMPLETED Phase 1

TAA-Specific CTLS for Solid Tumors (TACTASOM)

NCT02239861

COMPLETED

CRIC-Visceral Adiposity and Physical Fitness in Chronic Kidney Disease

NCT02405650

COMPLETED NA

Detecting Errors In Using Metered Dose Inhalers (MDI) Among Asthma And Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT02447575

COMPLETED NA

The Houston HIITBAC for African Americans

NCT02253433

COMPLETED NA

Lifestyle Intervention for Senior Diabetics

NCT02348801

TERMINATED NA

Fetal Cystoscopy for Lower Urinary Tract Obstruction

NCT02446184

TERMINATED Phase 2

Treatment of Hemoglobin SC Disease With Hydroxyurea

NCT02336373

COMPLETED NA

CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients

NCT02414672

COMPLETED Phase 1

Energetics and Function in Older Humans

NCT02348762

COMPLETED Phase 1

Glutathione and Function in HIV Patients

NCT02348775

COMPLETED NA

Calmer Life: Treating Worry Among Older Adults In Underserved, Low-income, Minority Communities

NCT02391363

COMPLETED NA

Improving Self-Management in Head and Neck Cancer

NCT02409485

COMPLETED Phase 1

Safety and Immunogenicity Study of Na-GST-1 With or Without CpG

NCT02143518

COMPLETED NA

Comparative Efficacy of Phenylbutyrate (PBA) vs. Benzoate in Urea Cycle Disorders

NCT02111200

COMPLETED NA

Nitric Oxide Supplementation in Argininosuccinic Aciduria

NCT02252770

COMPLETED NA

Microbiome Fructan Metabolism and Symptoms in Childhood IBS

NCT02842281

TERMINATED NA

Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection

NCT02198833

TERMINATED NA

Comparing Nasal Suction Devices in Children With Bronchiolitis: A Pilot Study

NCT02219334

COMPLETED NA

Promoting The Self-Regulation Of Energy Intake

NCT01513343

COMPLETED NA

The IMPULSE Study: Pilot

NCT02044471

COMPLETED Phase 1

Peanut Oral Immunotherapy in Children With Peanut Allergy (Peanut Flour)

NCT02203799

COMPLETED Phase 1

Fetoscopic Meningomyelocele Repair Study

NCT02230072

COMPLETED NA

A Pilot Study To Evaluate The Preliminary Safety And Feasibility Of The Materna Medical Device

NCT02332759

COMPLETED NA

Diabetes Strengths Study - Pilot of Provider-delivered Strengths-based Intervention

NCT02510664

COMPLETED Phase 4

A Trial Comparing Single Intra-op Dose of Methadone Versus Placebo in Patients Undergoing Spine Surgery

NCT02206685

COMPLETED NA

Video Games for Obesity and Diabetes Prevention-Diab & Nano

NCT01846377

TERMINATED NA

The Effects of Cyclosporin A in a Low Humidity Environment, on the Ocular Surface

NCT02199964

COMPLETED Phase 1

Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in Children

NCT01947101

← Previous Page 7 of 13 Next →

Phase Distribution

PhaseTrial count
Phase 1 173
Phase 2 59
Phase 3 13
Phase 4 46

What is open in the Baylor College of Medicine pipeline

93 recruiting of 616 indexed (15% open); 376 completed (61%).

Phase mix: 59 late (III/IV) vs 232 early (I/II) (early-phase heavy).

Top condition: Non-Hodgkin Lymphoma (7 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Baylor College of Medicine: open-pipeline peers nationwide

Peers matched on 616 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 0%5%10%15%20% Total trials Recruiting share Baylor College of MedicineUniversity of Southern CaliforniaUS Department of Veterans AffairsUniversity of RochesterJanssen Research & DevelopmentStanford UniversityBaylor UniversityCornell University59th Medical Wing
Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 616 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Baylor College of Medicine page

616 registered trials is a research-attention snapshot, not an endorsement of Baylor College of Medicine or any single study.

  • 93 of Baylor College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Non-Hodgkin Lymphoma is the condition Baylor College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Non-Hodgkin Lymphoma trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Baylor College of Medicine pipeline card: 616 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.